MedTrace Logo

A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)

NCT05620056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 564760

Last updated 2022-11-17

No results posted yet for this study

Summary

The DEEP cohort is the first population-based cohort of pregnant population in China that longitudinally documents drug uses throughout the pregnancy life course and adverse pregnancy outcomes.

Conditions

  • Pregnancy
  • Congenital Malformation
  • Drug Exposure

Interventions

DRUG

chemicals drugs, biological products, patent Chinese Medicines, Chinese herbs

medication (i.e., chemicals drugs, biological products, patent Chinese Medicines, Chinese herbs ) exposure through the pregnancy life course

Sponsors & Collaborators

  • Xiamen Health Commission

    collaborator UNKNOWN

  • Xiamen Health and Medical Big Data Center

    collaborator UNKNOWN

  • West China Hospital

    lead OTHER

Principal Investigators

  • Xin Sun · Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, China

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2021-12-31
Completion
2022-11-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05620056 on ClinicalTrials.gov